Bioventus (BVS) Treasury Shares (2021 - 2026)

Bioventus' Treasury Shares history runs 6 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• Quarterly Treasury Shares rose 35.04% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 35.04% YoY) and the FY2025 annual result came in at $159000.0, down 93.41% from the prior year.
• Treasury Shares was $4.0 million for Q1 2026 at Bioventus, up from $159000.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $4.0 million in Q1 2026 and bottomed at $159000.0 in Q2 2025.
• A 5-year average of $2.0 million and a median of $2.2 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 593.69% — and 2025, when it sank 94.4%.
• Bioventus' Treasury Shares stood at $1.2 million in 2022, then surged by 73.76% to $2.1 million in 2023, then climbed by 16.75% to $2.4 million in 2024, then slumped by 93.41% to $159000.0 in 2025, then jumped by 2403.77% to $4.0 million in 2026.
• Business Quant data shows BVS's Treasury Shares at $4.0 million in Q1 2026, $159000.0 in Q4 2025, and $2.8 million in Q3 2025.